cas 110-03-2|| where to buy 2,5-Dimethyl-2,5-hexanediol

Product Name:2,5-Dimethyl-2,5-hexanediol

IUPAC Name:2,5-dimethylhexane-2,5-diol

Packing Unit	Available Stock	Price($)
CM115943-100g	1-2 Weeks	ţǎ
CM115943-500g	3-4 Weeks	ǭĜţ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 110-03-2 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:110-03-2; Molecular Formula:C8H18O2; Melting Point:-; Smiles Code:CC(O)(C)CCC(O)(C)C; Density:

: Catalog Number:CM115943; Molecular Weight:146.23; Boiling Point:214-215°C at 760 mmHg; MDL No:MFCD00004473; Storage:Store at 2-8°C.

: Aliphatic Chain Compounds; Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.

: Alcohols; Alcohol is a type of organic compound that carries at least one hydroxyl ( −OH) functional group bound to a saturated carbon atom.

: Palovarotene; A breakthrough treatment raises hopes for rare bone disease. Palovarotene (Sohonos) has been recently approved by the FDA as a retinoid indicated for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare progressive genetic disease effecting one in a million individuals. This first and only treatment is able to effectively reduce the formation of new abnormal bone in soft and connective tissues.